SCHEMBL23809229

SCHEMBL23809229

COCCOc1cc(C(C)C)c2c(c1)cc(C(=O)O)n2Cc1cccc(C)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 3/20 0.36
RET P07949 1/20 0.36
THRA P10827 3/20 0.35
THRB P10828 3/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CCR2 P41597 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34
CSF1R P07333 2/20 0.33
S1PR3 Q99500 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23809384 0.89 KMT2A (0.40) KMT2AMEN1CCR2KDM4EALDH1A1
SCHEMBL23809200 0.89 KDM4E (0.41) MCL1THRATHRBKDM4EALDH1A1
SCHEMBL26581364 0.89 MCL1 (0.42) MCL1RETTHRATHRBKMT2A
SCHEMBL23809399 0.88 KDM4E (0.46) MCL1KMT2AMEN1KDM4EALDH1A1
SCHEMBL23809507 0.84 ALDH1A1 (0.37) KMT2ACCR2ALDH1A1
SCHEMBL30547735 0.82 CCR2 (0.46) MCL1CCR2KDM4EALDH1A1HPGD
SCHEMBL26037497 0.77 KDM4E (0.42) MCL1THRATHRBKDM4EALDH1A1
SCHEMBL26581349 0.77 MEN1 (0.42) MCL1KMT2AMEN1CCR2KDM4E
SCHEMBL26581352 0.77 KDM4E (0.46) MCL1KMT2AMEN1NPC1RAB9A
SCHEMBL23809228 0.77 KDM4E (0.43) MCL1THRATHRBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423435-B1 SUBSTITUTED INDOLE MCL-1 INHIBITORS UNIV VANDERBILT (US) 2023-08-23 EP disclosed
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 MCL1 1/4885RET 2403/4885THRA 4534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.